Document is current
Any future updates will be listed below
-
Authors
Bootpetch, Tori C.
Hafrén, Lena
Elling, Christina L.
Baschal, Erin E.
Manichaikul, Ani W.
Pine, Harold S.
Szeremeta, Wasyl
Scholes, Melissa A.
Cass, Stephen P.
Larson, Eric D.
Chan, Kenny H.
Ishaq, Rafaqat
Prager, Jeremy D.
Shaikh, Rehan S.
Gubbels, Samuel P.
Yousaf, Ayesha
,
Bamshad, Michael J.
Nickerson, Deborah A.
Leal, Suzanne M.
Wine, Todd M.
Bamshad, Michael J.
Yoon, Patricia J.
Jenkins, Herman A.
Nickerson, Deborah A.
Streubel, Sven-Olrik
Friedman, Norman R.
Frank, Daniel N.
Einarsdottir, Elisabet
Kere, Juha
Riazuddin, Saima
Daly, Kathleen A.
Leal, Suzanne M.
Ryan, Allen F.
Mattila, Petri S.
Ahmed, Zubair M.
Sale, Michele M.
Chonmaitree, Tasnee
Santos-Cortez, Regie Lyn P.
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (UM1 HG006493, UM1 HG006493, UM1 HG006493, UM1 HG006493)
National Heart, Lung, and Blood Institute (U24 HG008956, U24 HG008956, U24 HG008956, U24 HG008956)
National Institute on Deafness and Other Communication Disorders (R01 DC015004)
- License Information
-
More Information
Article History
Received: 18 November 2019
Accepted: 30 July 2020
First Online: 14 September 2020
Competing interests
: Dr. Allen Ryan is a co-founder of, shareholder in and uncompensated consultant to Otonomy, Inc., a relationship that was approved by the University of California San Diego. All other authors declare no competing interests.
